Single Dose Intranasal Oxytocin and Cognitive Effects in Autism
ClinicalTrials.gov · NCT02493426 · Registry updated: 2023-01-23
- Condition / research focus
- Autism Spectrum Disorders
- Sponsor
- University of Minnesota
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2014-05. Completion: 2021-03-31 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Intranasal Oxytocin (drug)
- Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Center for Neurobehavioral Development
Minneapolis, Minnesota, United States
Site recruitment: Not reported